Current status of surgical treatment of secondary hyperparathyroidism
10.3760/cma.j.issn115396-20211004-00390
- VernacularTitle:继发性甲状旁腺功能亢进症外科治疗现状
- Author:
Yue YU
1
;
Yaohua WU
Author Information
1. 哈尔滨医科大学附属第一医院甲状腺外科，哈尔滨 150001
- Keywords:
Hyperparathyroidism, secondary;
Parathyroid hormone;
Parathyroidectomy
- From:
International Journal of Surgery
2022;49(2):117-121
- CountryChina
- Language:Chinese
-
Abstract:
Secondary hyperparathyroidism (SHPT) is the most common complication of chronic kidney disease. It is usually manifested as a series of symptoms such as bone and joint pain, bone deformity, limb numbness and fatigue, which seriously affect the quality of patients’life. Effective therapeutic interventions are very important to reduce the mortality and morbidity of SHPT patients. For most early stage patients, durg therapy combined with adequate dialysis is very effective for disease control, but as the disease progresses, SHPT will enter the irrevesible stage and patients will become resistant to durg therapy. Surgery is the only effective treatment for advanced SHPT. However, there are still some problems such as different surgical methods, unclear surgical indications, higher perioperative risk and recurrence rate, surgery has not been widely used in clinical treatment. Now the present status of surgery treatment of SHPT is introduced in order to provide reference for the further research and development of surgery treatment.
